Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer

Journal of Clinical Oncology

Volumn 36, Issue 12, 2018, Pages 1184-1191

  Clarke, Megan A ^a   Fetterman, Barbara ^c   Cheung, Li C ^a   Wentzensen, Nicolas ^a   Gage, Julia C ^a   Katki, Hormuzd A ^a   Befano, Brian ^b   Demarco, Maria ^a   Schussler, John ^b   Kinney, Walter K ^c   Raine Bennett, Tina R ^d   Lorey, Thomas S ^c   Poitras, Nancy E ^c   Castle, Philip E ^e   Schiffman, Mark ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d KAISER PERMANENTE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BODY MASS; BODY WEIGHT GAIN; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONFERENCE PAPER; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PRECANCER; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNDERWEIGHT; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; AGE; CALIFORNIA; EARLY CANCER DIAGNOSIS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UTERINE CERVIX TUMOR; VIROLOGY;

VIRUS DNA;

ADULT; AGE FACTORS; CALIFORNIA; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; OBESITY; OVERWEIGHT; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 85045656259     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2017.75.3442     Document Type: Conference Paper

References (35)

1. Afshin A, Forouzanfar MH, Reitsma MB, et al: Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377:13-27, 2017
2. Flegal KM, Kruszon-Moran D, Carroll MD, et al: Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315:2284-2291, 2016
3. Reeves GK, Pirie K, Beral V, et al: Cancer incidence and mortality in relation to body mass index in theMillion Women Study: Cohort study. BMJ 335: 1134, 2007
4. Poorolajal J, Jenabi E: The association between BMI and cervical cancer risk: A meta-analysis. Eur J Cancer Prev 25:232-238, 2016
5. Lacey JV Jr, Swanson CA, Brinton LA, et al: Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 98:814-821, 2003
6. Kizer NT, Thaker PH, Gao F, et al: The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. Cancer 117:948-956, 2011
7. Frumovitz M, Jhingran A, Soliman PT, et al: Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol 124:1098-1104, 2014
8. Calle EE, Rodriguez C, Walker-Thurmond K, et al: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638, 2003
9. Lee JK, So KA, Piyathilake CJ, et al: Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS One 8:e66555, 2013
10. Bhaskaran K, Douglas I, Forbes H, et al: Bodymass index and risk of 22 specific cancers: A population-based cohort study of 5$24 million UK adults. Lancet 384:755-765, 2014
11. Maruthur NM, Bolen SD, Brancati FL, et al: The association of obesity and cervical cancer screening: A systematic review and meta-analysis. Obesity (Silver Spring) 17:375-381, 2009
12. Castle PE, Kinney WK, Cheung LC, et al: Why does cervical cancer occur in a state-of-the-art screening program?. Gynecol Oncol 146:546-553, 2017
13. Uppot RN, Sahani DV, Hahn PF, et al: Effect of obesity on image quality: Fifteen-year longitudinal study for evaluation of dictated radiology reports. Radiology 240:435-439, 2006
14. Bañez LL, Hamilton RJ, Partin AW, et al: Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 298:2275-2280, 2007
15. Amy NK, Aalborg A, Lyons P, et al: Barriers to routine gynecological cancer screening for White and African-American obese women. Int J Obes 30: 147-155, 2006
16. Bates CK, Carroll N, Potter J: The challenging pelvic examination. J Gen Intern Med 26:651-657, 2011
17. Katki HA, Kinney WK, Fetterman B, et al: Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: A population-based study in routine clinical practice. Lancet Oncol 12:663-672, 2011
18. Arbyn M, Bergeron C, Klinkhamer P, et al: Liquid compared with conventional cervical cytology: A systematic review and meta-analysis. Obstet Gynecol 111:167-177, 2008
19. Solomon D, Davey D, Kurman R, et al: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287:2114-2119, 2002
20. Massad LS, Einstein MH, Huh WK, et al: 2012 ASCCP Consensus Guidelines Conference: 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 17:S1-S27, 2013 (suppl 1)
21. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary-Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 68:899-917, 1998
22. Stoler MH, Schiffman M: Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group: Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL triage study. JAMA 285:1500-1505, 2001
23. Castle PE, Stoler MH, Solomon D, et al: The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: An ALTS report. Am J Clin Pathol 127:805-815, 2007
24. Schiffman M, Wentzensen N: Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev 22:553-560, 2013
25. Cheung LC, Pan Q, Hyun N, et al: Mixture models for undiagnosed prevalent disease and interval-censored incident disease: Applications to a cohort assembled from electronic health records. Stat Med 36:3583-3595, 2017
26. Schatzkin A, Freedman LS, Dorgan J, et al: Surrogate end points in cancer research: A critique. Cancer Epidemiol Biomarkers Prev 5: 947-953, 1996
27. Song YM, Sung J, Ha M: Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 26:3395-3402, 2008
28. Kaplan SA: Re: The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy. J Urol 194:394-395, 2015
29. Wright TC Jr, Massad LS, Dunton CJ, et al: 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 11: 223-239, 2007
30. Wright TC Jr, Cox JT, Massad LS, et al: 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. J Low Genit Tract Dis 7:154-167, 2003
31. Ogden CL, Carroll MD, Fryar CD, et al: Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief 219:1-8, 2015 https://www.cdc.gov/nchs/products/databriefs/ db219.htm
32. Sternfeld B,Wang H,Quesenberry CP Jr, et al: Physical activity and changes in weight and waist circumference in midlife women: Findings from the Study of Women's Health Across the Nation. Am J Epidemiol 160:912-922, 2004
33. Lee IM, Djoussé L, Sesso HD, et al: Physical activity and weight gain prevention. JAMA 303: 1173-1179, 2010
34. Drøyvold WB, Nilsen TI, Krüger O, et al: Change in height, weight and body mass index: Longitudinal data from the HUNT Study in Norway. Int J Obes 30:935-939, 2006
35. Bosch FX, Broker TR, Forman D, et al: Comprehensive control of human papillomavirus infections and related diseases. Vaccine 31:I1-I31, 2013 (suppl 8)